Clinical Trial

Calcific Tendinitis: Comparing Minimally Invasive Modalities

Study Description

Calcific Tendinitis: Comparing Minimally Invasive Modalities

Calcific tendinitis is a common and challenging problem in the orthopedic surgeon's office. The chronic and variable course of the condition can lead to dissatisfaction with conservative management. Current standard of care at the Thunder Bay Regional Health Sciences Centre is referral for treatment by either needle decompression therapy by a radiologist or shockwave therapy by a physiotherapist. The purpose of this study is to compare the efficacies of these treatment options.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Recruiting patients only Recruiting patients only

Procedure - Needle decompression

Direct manipulation of calcium deposits in the shoulder with a needle to fragment the deposit performed by a radiologist.

Procedure - Shockwave therapy

A physiotherapist performs the shockwave therapy procedure. Treatment is completed in 4 weekly sessions. Treatment involves applying soundwaves directly to the affected shoulder area using an ultrasound device.

Drug - Depo medrol

Subacromial steroid injection (40 mg depo medrol) is given to the patient to limit irritation following needle decompression.

Device - Ultrasound device

Ultrasound device is applied directly to the shoulder at 0.2 mJ/mm2.

Additional Information

Official Study Title

Calcific Tendinitis: Comparing Minimally Invasive Modalities

Clinical Trial ID

NCT02367560

ParticipAid ID

Le3j4d